Unlock the Shocking Truth: This One Healthy Habit Can Slash Your Heart Risks More Than Meds!

A recent study underscores the significance of maintaining a healthy lifestyle for individuals with type 2 diabetes, even when using medications such as glucagon-like peptide-1 (GLP-1) receptor agonists. This research highlights the critical role that diet and exercise play in minimizing cardiovascular risk associated with diabetes.

According to the study published in the Lancet Diabetes & Endocrinology, patients who combined GLP-1 medications with healthy lifestyle habits—such as adhering to a high-quality diet, engaging in regular physical activity, and ensuring adequate sleep—experienced a substantially greater reduction in major adverse cardiovascular events (MACE). Specifically, those who followed six or more healthy habits enjoyed a remarkable 43% reduction in risk compared to those taking GLP-1 drugs alone, which only showed a 16% relative risk reduction.

Dr. Frank B. Hu, senior researcher at the Harvard T.H. Chan School of Public Health in Boston, noted the study's pivotal findings, stating, “Individuals who use the GLP-1 and also adhered to six or more healthy habits had a 43% reduction in risk, which is quite remarkable.” He further explained that adopting a healthy diet does not require perfection; even moderate adherence can significantly enhance the cardiovascular benefits associated with GLP-1 use.

The analysis included data from 98,261 US veterans (only 5.5% of whom were women) with type 2 diabetes who participated in the Department of Veterans Affairs’ Million Veteran Program between 2011 and 2023. With nearly a decade’s worth of data, this study is one of the largest to assess the combined effects of GLP-1 treatments and lifestyle changes.

Historically, the intersection of GLP-1 treatments and lifestyle interventions has been underexplored. Past studies focused largely on short-term impacts, primarily examining how physical activity can help sustain weight loss after discontinuing medication. However, the Million Veteran Program provided extensive self-reported surveys detailing lifestyle factors such as eating habits, exercise routines, smoking status, sleep quality, alcohol consumption, stress management, and social connections.

Researchers assessed lifestyle scores based on adherence to eight healthy habits, which were scored from 0 to 8. A quality diet was defined using the healthy plant-based index, while sufficient physical activity was quantified based on frequency and intensity. The study followed participants for over 632,543 person-years, during which 10,443 participants developed MACE, a composite endpoint that includes myocardial infarction, stroke, or cardiovascular death.

Among the participants, 13,394 reported using a GLP-1 receptor agonist. The use of these medications was linked to a 16% lower risk of experiencing MACE when compared to non-users. Dr. Hu expressed satisfaction with the findings, noting, “The relative reduction in MACE risk among GLP-1 users is exactly the same as the risk reduction from SELECT, a large randomized, controlled trial.”

Adjustments for various factors, including diabetes duration and other cardiovascular risk factors, revealed that participants who adhered to all eight healthy habits had a 60% lower risk of MACE compared to those who followed only one or none. Interestingly, only 1% of veterans in the study managed to adopt all eight habits.

Additionally, the research indicated a graded response among GLP-1 users based on lifestyle adherence. Those who adhered to four, five, and six healthy habits experienced respective relative risks of MACE reduction of 27%, 35%, and 42% when compared to those who had a score of 0-1. This data reveals a clear correlation between lifestyle choices and enhanced health outcomes.

Dr. Hu emphasized the importance of not disregarding lifestyle changes in an era where powerful weight-loss medications are available. He remarked that relying solely on medication for health issues is a naive approach. “Diet and lifestyle not only have independent effects on cardiovascular outcomes, but [lifestyle] can amplify effects and also reduce the side effects and complications associated with GLP-1 use,” Hu stated.

For instance, engaging in regular exercise and maintaining a healthy diet can mitigate the loss of muscle mass that some users of GLP-1 medications may experience. Furthermore, lifestyle modifications can help prevent weight gain if individuals choose to discontinue their medications due to side effects.

In a related editorial, Drs. Stefano Del Prato and Anna Solini from the University of Pisa, Italy, suggested that the benefits of a healthy lifestyle among GLP-1 users might be understated since participants reported their habits predominantly at the study's outset. They posited that sustained adherence could yield even more significant long-term effects.

As research continues, Dr. Hu and his team plan to conduct further analyses involving individuals without type 2 diabetes, expanding the understanding of lifestyle impacts on cardiovascular health across a broader population.